Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Alternative treatments with nutrients, minerals, and vitamins are being explored for safer hair loss management.

Chemotherapy caused a woman's permanent hair loss and early menopause.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Minoxidil effectively treats stress-induced non-scarring hair loss.

Alopecia, especially androgenic, may increase cardiovascular risk, but more research is needed.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Scalp sensations like burning are linked to psychological distress in some types of hair loss.

PRP shows promise for treating certain types of hair loss.

Microtrauma techniques like microneedling and PRP can help regrow hair in non-scarring alopecia.

AI can help track and improve hair loss treatment outcomes.

Telogen effluvium most affects quality of life in alopecia patients.

Platelet-rich plasma can help treat scarring hair loss caused by Discoid Lupus Erythematosus.

Patients with non-scarring alopecia often experience emotional disorders like depression and stress.

Trichoscopy helps diagnose and manage different types of hair loss in the Indian population.

Dermoscopy helps diagnose different types of hair loss and may reduce the need for biopsies.

People with non-scarring hair loss have higher levels of DKK-1, a protein linked to hair growth, than those with scarring hair loss or no hair loss.

Chemical relaxers may cause scarring alopecia in black women.

A baby boy had two types of temporary hair loss at birth, which might be two forms of newborn hair loss combined.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Ingrown hairs are a common feature in scarring alopecias due to follicular damage.

Eating more antioxidant-rich foods and less alcohol may help reduce hair loss.